Trial ID or NCT#

NCT01127061

Status

NOT RECRUITING

Purpose

The investigators propose a pilot randomized controlled trial to determine the safety and potential benefits of moderate intensity exercise in patients with hypertrophic cardiomyopathy. The investigators hypotheses are that exercise parameters derived from a baseline cardiopulmonary exercise test will target an appropriately safe level of exercise intensity that will not cause significant arrhythmias or exacerbate symptoms and that exercise training for 4 months will result in significant improvements in peak oxygen consumption and quality of life, with neutral effects on the clinical characteristics.

Official Title

A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Euan A. Ashley
Cardiologist
Professor of Medicine (Cardiovascular) and, by courtesy, of Pathology at the Stanford University Medical Center
Matthew Wheeler
Cardiologist
Clinical Assistant Professor, Medicine - Cardiovascular Medicine

Contact us to find out if this trial is right for you.

CONTACT

Heidi Salisbury, RN, MSN
(650) 736-7878